Kronox Lab Sciences Live Share Price Today, Share Analysis and Chart

About the company - Business Profile

Kronox Lab Sciences Ltd. is a manufacturer of high-purity specialty fine chemicals used across various industries, including pharmaceuticals, nutraceuticals, biotech, agrochemicals, and scientific research. The company produces a wide range of chemical products, including phosphates, sulfates, acetates, chlorides, citrates, and EDTA derivatives, adhering to international standards such as IP, BP, EP, JP, USP, and FCC. Strategically located near Vadodara, Gujarat, Kronox focuses on high-quality standards and custom manufacturing to meet specific client requirements.

Key Points

• Key Facts:
  • Founded Year: Incorporated as a private limited company on November 18, 2008; transitioned to a public limited company on May 25, 2019.
  • Headquarters: Vadodara, Gujarat, India.
  • Stock Listing: Listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in 2024.
  • Products: Over 185 chemical products spanning various families like phosphates, sulfates, acetates, chlorides, citrates, nitrates, nitrites, carbonates, EDTA derivatives, succinates, and gluconates.
• Operations and Resources:
  • Manufacturing Facilities: Operates three strategically located manufacturing units near Vadodara, Gujarat, with a cumulative area of 1.88 lakh sq. ft.
  • Capacity: Total installed capacity is 7,242 MTPA as of FY2025.
  • Certifications: Units hold various certifications, including FSSC 22000 (Unit I), ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 (Units I & II), GMP, GLP, Kosher, and Halal (Unit I).
• Market and Significance:
  • Industries Served: Pharmaceuticals, scientific research, nutraceuticals, biotech, agrochemicals, personal care, metallurgy, and animal health.
  • Global Reach: Exports contributed 26.57% of total revenue in FY2025, reaching over 20 countries.
• Business Model and Strengths:
  • Kronox operates on a business model centered on the production of high-purity specialty chemicals with stringent quality requirements.
  • The company excels in maintaining high-purity levels (up to 99.9% or higher) and offers custom-made specifications for its clients.
  • High entry barriers exist due to the technical expertise required, long customer qualification processes, and significant investment in R&D and testing facilities.
• Financial Performance (FY2025):
  • Revenue from Operations: ₹10,019.39 lakhs in FY2025 compared to ₹9,558.29 lakhs in FY2024.
  • EBITDA: ₹3,313 lakhs with an EBITDA margin of 33.06%.
  • Profit After Tax (PAT): ₹2,483.67 lakhs with a PAT margin of 24.79%.
  • Revenue Breakdown: For FY2025, exports accounted for 26.57% of revenue, while the remainder was primarily from domestic sales. The company operates in a single reportable segment: manufacturing of High Purity Specialty Fine Chemicals.
• Key Products and Technology:
  • Core offerings include High Purity Speciality Fine Chemicals available in different grades and particle sizes (10 mesh to 100 mesh).
  • The company utilizes a fully equipped laboratory for testing and quality control to ensure adherence to international pharmacopoeia standards.
• Strategic Initiatives and Future Outlook:
  • Expansion: The company is setting up a new manufacturing plant (Unit IV) at Dahej, Bharuch district, on a land area of 20,471 sq. m. to significantly increase its production capacity.
  • Listing: Successfully completed its Initial Public Offering (IPO) and listed its shares on NSE and BSE in June 2024.
  • Growth: Focus remains on expanding the product portfolio and increasing penetration in international markets.

References

1. Annual Report May 2025
2. Annual Report Jul 2024
3. Result Nov 2025
4. Result Feb 2026